BioMarin Pharmaceutical Inc. (United States) is linked to 1 FDA-registered manufacturing site. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “BioMarin Pharmaceutical Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/biomarin-pharmaceutical-inc

Overview

BioMarin Pharmaceutical Inc. is a biotechnology company that specializes in developing and commercializing innovative therapies for rare genetic diseases. The company focuses on providing treatments for diseases with serious unmet medical needs, leveraging its expertise in enzyme replacement therapies and gene therapies.

Therapeutic areas

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to BioMarin Pharmaceutical Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832020-02-28

    Late submission of annual safety reports

  • 4832009-03-20

    Extent of discrepancy, failure investigations

  • 4832009-03-20

    Control procedures to monitor and validate performance

For suppliers

Is this BioMarin Pharmaceutical Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.